163(top 100%)
papers
27.6K(top 1%)
citations
78(top 100%)
h-index
172(top 100%)
g-index
189
all documents
32.4K
doc citations
3.3K
citing journals
100
times ranked

Publications

169 papers • 32,377 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
Nature, 2023, 617, 377-385
34.3148Citations (PDF)
2Gut microbial fatty acid isomerization modulates intraepithelial T cells
Nature, 2023, 619, 837-843
34.392Citations (PDF)
3Harnessing Colon Chip Technology to Identify Commensal Bacteria That Promote Host Tolerance to Infection4.239Citations (PDF)
4Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis’ Polysaccharide A5.038Citations (PDF)
5Host immunomodulatory lipids created by symbionts from dietary amino acids
Nature, 2021, 600, 302-307
34.3102Citations (PDF)
6Microbiota-targeted maternal antibodies protect neonates from enteric infection
Nature, 2020, 577, 543-548
34.3137Citations (PDF)
7Transcriptional and proteomic insights into the host response in fatal COVID-19 cases7.5189Citations (PDF)
8Commensal Microbiota Modulation of Natural Resistance to Virus Infection
Cell, 2020, 183, 1312-1324.e10
28.6259Citations (PDF)
9Fiber Sets up the Battleground for Intestinal Prevotella
Cell Host and Microbe, 2020, 28, 776-777
10.612Citations (PDF)
10An Immunologic Mode of Multigenerational Transmission Governs a Gut Treg Setpoint
Cell, 2020, 181, 1276-1290.e13
28.6158Citations (PDF)
11When Lab Mice Go Wild, Fungi Are in Play
Cell Host and Microbe, 2020, 27, 687-688
10.63Citations (PDF)
12A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip24.8719Citations (PDF)
13Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to<i>Francisella tularensis</i>7.536Citations (PDF)
14Surface Structures of Group B<i>Streptococcus</i>Important in Human Immunity3.625Citations (PDF)
15Symbionts exploit complex signaling to educate the immune system7.5114Citations (PDF)
16Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines7.597Citations (PDF)
17A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III
Clinical Infectious Diseases, 2019, 68, 2079-2086
5.643Citations (PDF)
18Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Nature, 2019, 577, 410-415
34.3867Citations (PDF)
19Finding a needle in a haystack: <i>Bacteroides fragilis</i> polysaccharide A as the archetypical symbiosis factor4.663Citations (PDF)
20Mining the Human Gut Microbiota for Immunomodulatory Organisms
Cell, 2017, 168, 928-943.e11
28.6681Citations (PDF)
21An Intestinal Organ Culture System Uncovers a Role for the Nervous System in Microbe-Immune Crosstalk
Cell, 2017, 168, 1135-1148.e12
28.6226Citations (PDF)
22Building conventions for unconventional lymphocytes
Immunological Reviews, 2017, 279, 52-62
6.819Citations (PDF)
23Illuminating vital surface molecules of symbionts in health and disease16.5114Citations (PDF)
24The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4
PLoS ONE, 2017, 12, e0172738
2.567Citations (PDF)
25Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis
PLoS ONE, 2017, 12, e0188600
2.57Citations (PDF)
26Moving beyond microbiome-wide associations to causal microbe identification
Nature, 2017, 552, 244-247
34.3256Citations (PDF)
27Early Interactions of Murine Macrophages with Francisella tularensis Map to Mouse Chromosome 19
MBio, 2016, 7,
4.56Citations (PDF)
28How colonization by microbiota in early life shapes the immune system
Science, 2016, 352, 539-544
19.51,773Citations (PDF)
29Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice7.5393Citations (PDF)
30Veggies and Intact Grains a Day Keep the Pathogens Away
Cell, 2016, 167, 1161-1162
28.67Citations (PDF)
31A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance
Nature Medicine, 2016, 22, 421-426
36.5529Citations (PDF)
32A commensal symbiotic factor derived from<i>Bacteroides fragilis</i>promotes human CD39<sup>+</sup>Foxp3<sup>+</sup>T cells and T<sub>reg</sub>function
Gut Microbes, 2015, 6, 234-242
10.2234Citations (PDF)
33In vivo imaging and tracking of host–microbiota interactions via metabolic labeling of gut anaerobic bacteria
Nature Medicine, 2015, 21, 1091-1100
36.5227Citations (PDF)
34Gut Commensal Immunomodulatory Factors: Identification and Structure‐Function Studies
FASEB Journal, 2015, 29,
0.70Citations (PDF)
35Sphingolipids of Commensals Modulate Host Immunity through Regulation of iNKT Cells
FASEB Journal, 2015, 29,
0.70Citations (PDF)
36Interactions between the intestinal microbiota and innate lymphoid cells
Gut Microbes, 2014, 5, 129-140
10.227Citations (PDF)
37Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells
Cell, 2014, 156, 123-133
28.6590Citations (PDF)
38Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules
FEMS Microbiology Reviews, 2014, 38, 660-697
11.0238Citations (PDF)
39An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling14.2193Citations (PDF)
40Plasmacytoid Dendritic Cells Mediate Anti-inflammatory Responses to a Gut Commensal Molecule via Both Innate and Adaptive Mechanisms
Cell Host and Microbe, 2014, 15, 413-423
10.6277Citations (PDF)
41Deciphering the tête-à-tête between the microbiota and the immune system9.192Citations (PDF)
42The atypical lipopolysaccharide ofFrancisella
Carbohydrate Research, 2013, 378, 79-83
2.344Citations (PDF)
43Testosterone: More Than Having the Guts to Win the Tour de France
Immunity, 2013, 39, 208-210
16.718Citations (PDF)
44Carbohydrates and T cells: A sweet twosome
Seminars in Immunology, 2013, 25, 146-151
6.689Citations (PDF)
45Resident commensals shaping immunity5.664Citations (PDF)
46Kdo Hydrolase Is Required for Francisella tularensis Virulence and Evasion of TLR2-Mediated Innate Immunity
MBio, 2013, 4,
4.526Citations (PDF)
47Relevance of Commensal Microbiota in the Treatment and Prevention of Inflammatory Bowel Disease
Inflammatory Bowel Diseases, 2013, 19, 2478-2489
2.419Citations (PDF)
48Role of Murine Intestinal Interleukin-1 Receptor 1-Expressing Lymphoid Tissue Inducer-Like Cells in Salmonella Infection
PLoS ONE, 2013, 8, e65405
2.516Citations (PDF)
49Genetic Modification of the O-Polysaccharide of Francisella tularensis Results in an Avirulent Live Attenuated Vaccine
Journal of Infectious Diseases, 2012, 205, 1056-1065
4.035Citations (PDF)
50Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota
Cell, 2012, 149, 1578-1593
28.61,193Citations (PDF)
51Isolation of carbohydrate-specific CD4+ T cell clones from mice after stimulation by two model glycoconjugate vaccines
Nature Protocols, 2012, 7, 2180-2192
24.742Citations (PDF)
52Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Science, 2012, 336, 489-493
19.51,544Citations (PDF)
53The <i>yin yang</i> of bacterial polysaccharides: lessons learned from <i>B. fragilis</i> PSA
Immunological Reviews, 2012, 245, 13-26
6.8143Citations (PDF)
54Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: Implications for bacterial intracellular growth assay in macrophages1.77Citations (PDF)
55The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis3.960Citations (PDF)
56Regulation of T cells by gut commensal microbiota4.227Citations (PDF)
57Characterization of the APC presenting a microbial polysaccharide to regulatory T cells
Inflammatory Bowel Diseases, 2011, 17, S11-S12
2.40Citations (PDF)
58A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
Nature Medicine, 2011, 17, 1602-1609
36.5338Citations (PDF)
59Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease
Inflammatory Bowel Diseases, 2011, 17, 298-307
2.453Citations (PDF)
60Bacteroides fragilis–Stimulated Interleukin-10 Contains Expanding Disease
Journal of Infectious Diseases, 2011, 204, 363-371
4.054Citations (PDF)
61Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species
Glycobiology, 2011, 21, 401-409
2.6244Citations (PDF)
62How Bacterial Carbohydrates Influence the Adaptive Immune System
Annual Review of Immunology, 2010, 28, 107-130
31.1224Citations (PDF)
63Beneficial effects of Bacteroides fragilis polysaccharides on the immune system3.4294Citations (PDF)
64Characterization of the O-antigen Polymerase (Wzy) of Francisella tularensis
Journal of Biological Chemistry, 2010, 285, 27839-27849
2.337Citations (PDF)
65Novel Tools for Modulating Immune Responses in the Host—Polysaccharides from the Capsule of Commensal Bacteria
Advances in Immunology, 2010, , 61-91
0.013Citations (PDF)
663-Deoxy-d-manno-octulosonic Acid (Kdo) Hydrolase Identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila
Journal of Biological Chemistry, 2010, 285, 34330-34336
2.319Citations (PDF)
67Orientations of the<i>Bacteroides fragilis</i>Capsular Polysaccharide Biosynthesis Locus Promoters during Symbiosis and Infection
Journal of Bacteriology, 2010, 192, 5832-5836
3.026Citations (PDF)
68Microbial Colonization Drives Expansion of IL-1 Receptor 1-Expressing and IL-17-Producing γ/δ T Cells
Cell Host and Microbe, 2010, 7, 140-150
10.6204Citations (PDF)
69Central Nervous System Demyelinating Disease Protection by the Human Commensal <i>Bacteroides fragilis</i> Depends on Polysaccharide A Expression
Journal of Immunology, 2010, 185, 4101-4108
0.6371Citations (PDF)
70Small Molecule Control of Virulence Gene Expression in Francisella tularensis
PLoS Pathogens, 2009, 5, e1000641
4.589Citations (PDF)
71Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination
Clinical Immunology, 2009, 130, 264-271
2.927Citations (PDF)
72Type I <i>Streptococcus pneumoniae</i> carbohydrate utilizes a nitric oxide and MHC II‐dependent pathway for antigen presentation
Immunology, 2009, 127, 73-82
4.864Citations (PDF)
73Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis
Vaccine, 2009, 27, 597-605
3.335Citations (PDF)
74A microbial symbiosis factor prevents intestinal inflammatory disease
Nature, 2008, 453, 620-625
34.32,295Citations (PDF)
75TLR-Independent Type I Interferon Induction in Response to an Extracellular Bacterial Pathogen via Intracellular Recognition of Its DNA
Cell Host and Microbe, 2008, 4, 543-554
10.6123Citations (PDF)
76Regulation of surface architecture by symbiotic bacteria mediates host colonization7.5114Citations (PDF)
77IFN-γ Regulated Chemokine Production Determines the Outcome of <i>Staphylococcus aureus</i> Infection
Journal of Immunology, 2008, 181, 1323-1332
0.6106Citations (PDF)
78Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR
Glycobiology, 2008, 18, 707-718
2.659Citations (PDF)
79Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching7.537Citations (PDF)
80Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway7.576Citations (PDF)
81Symbiotic commensal bacteria direct maturation of the host immune system2.436Citations (PDF)
82Induction of T helper 1‐like regulatory are induced by Capsular polysaccharide A (PSA) of Bacteroides fragilis through IFN‐r and Foxp3
FASEB Journal, 2008, 22, 501-501
0.70Citations (PDF)
83A Defined O-Antigen Polysaccharide Mutant of<i>Francisella tularensis</i>Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity
Infection and Immunity, 2007, 75, 2591-2602
2.868Citations (PDF)
84Group A Streptococcus Epidemiology and Vaccine Implications
Clinical Infectious Diseases, 2007, 45, 863-865
5.643Citations (PDF)
85Bacterial Glycans: Key Mediators of Diverse Host Immune Responses
Cell, 2006, 126, 847-850
28.6197Citations (PDF)
86A Mechanism for Neurodegeneration Induced by Group B Streptococci through Activation of the TLR2/MyD88 Pathway in Microglia
Journal of Immunology, 2006, 177, 583-592
0.6162Citations (PDF)
87The love–hate relationship between bacterial polysaccharides and the host immune system
Nature Reviews Immunology, 2006, 6, 849-858
38.9324Citations (PDF)
88A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2
Journal of Experimental Medicine, 2006, 203, 2853-2863
8.1273Citations (PDF)
89Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens
Cellular Microbiology, 2005, 7, 1398-1403
1.486Citations (PDF)
90Regulation of Virulence by a Two-Component System in Group B Streptococcus
Journal of Bacteriology, 2005, 187, 1105-1113
3.0126Citations (PDF)
91Modulation of surgical fibrosis by microbial zwitterionic polysaccharides7.542Citations (PDF)
92Role of Lipoteichoic Acid in the Phagocyte Response to Group B<i>Streptococcus</i>
Journal of Immunology, 2005, 174, 6449-6455
0.6130Citations (PDF)
93Effect of B7-2 and CD40 Signals from Activated Antigen-Presenting Cells on the Ability of Zwitterionic Polysaccharides To Induce T-Cell Stimulation
Infection and Immunity, 2005, 73, 2184-2189
2.835Citations (PDF)
94Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial "pan-genome"7.52,516Citations (PDF)
95Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides
Infection and Immunity, 2005, 73, 3096-3103
2.8229Citations (PDF)
96Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
Science, 2005, 309, 148-150
19.5526Citations (PDF)
97An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Cell, 2005, 122, 107-118
28.62,692Citations (PDF)
98Case 25-200525.140Citations (PDF)
99Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells
Journal of Clinical Investigation, 2005, 115, 2325-2327
9.13Citations (PDF)
100Zwitterionic Polysaccharides Stimulate T Cells with No Preferential Vβ Usage and Promote Anergy, Resulting in Protection against Experimental Abscess Formation
Journal of Immunology, 2004, 172, 1483-1490
0.654Citations (PDF)
101Polysaccharide Processing and Presentation by the MHCII Pathway
Cell, 2004, 117, 677-687
28.6329Citations (PDF)
102Biological chemistry of immunomodulation by zwitterionic polysaccharides
Carbohydrate Research, 2003, 338, 2531-2538
2.350Citations (PDF)
103Glycoconjugate vaccines to prevent group B streptococcal infections3.141Citations (PDF)
104CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism
Journal of Immunology, 2003, 170, 1958-1963
0.6220Citations (PDF)
105Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice
Journal of Immunology, 2003, 170, 84-90
0.680Citations (PDF)
106CORRECTION
Journal of Immunology, 2003, 170, 4411-4411
0.62Citations (PDF)
107Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions
Journal of Immunology, 2002, 169, 6149-6153
0.6144Citations (PDF)
108Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways
Journal of Immunology, 2002, 169, 3970-3977
0.6133Citations (PDF)
109Type III Group B Streptococcal Polysaccharide Induces Antibodies That Cross-React with Streptococcus pneumoniae Type 14
Infection and Immunity, 2002, 70, 1724-1738
2.840Citations (PDF)
110CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation
Journal of Experimental Medicine, 2002, 195, 1471-1478
8.193Citations (PDF)
111Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V<i>Streptococcus agalactiae</i>7.5466Citations (PDF)
112Role of T cells in abscess formation7.735Citations (PDF)
113Extensive surface diversity of a commensal microorganism by multiple DNA inversions
Nature, 2001, 414, 555-558
34.3348Citations (PDF)
114Novel Engagement of CD14 and Multiple Toll-Like Receptors by Group B Streptococci
Journal of Immunology, 2001, 167, 7069-7076
0.6138Citations (PDF)
115Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis
Infection and Immunity, 2001, 69, 4342-4350
2.895Citations (PDF)
116Functional Analysis in Type Ia Group B Streptococcusof a Cluster of Genes Involved in Extracellular Polysaccharide Production by Diverse Species of Streptococci2.3141Citations (PDF)
117Immunochemical and Biological Characterization of Three Capsular Polysaccharides from a Single Bacteroides fragilisStrain
Infection and Immunity, 2001, 69, 2339-2344
2.831Citations (PDF)
118Characterization of the Linkage between the Type III Capsular Polysaccharide and the Bacterial Cell Wall of Group BStreptococcus
Journal of Biological Chemistry, 2000, 275, 7497-7504
2.389Citations (PDF)
119Bacteroides fragilis NCTC9343 Produces at Least Three Distinct Capsular Polysaccharides: Cloning, Characterization, and Reassignment of Polysaccharide B and C Biosynthesis Loci
Infection and Immunity, 2000, 68, 6176-6181
2.850Citations (PDF)
120In Whose Best Interest? Breaching the Academic–Industrial Wall
New England Journal of Medicine, 2000, 343, 1646-1649
25.189Citations (PDF)
121Effect of Molecular Size on the Ability of Zwitterionic Polysaccharides to Stimulate Cellular Immunity
Journal of Immunology, 2000, 164, 719-724
0.657Citations (PDF)
122T Cells Activated by Zwitterionic Molecules Prevent Abscesses Induced by Pathogenic Bacteria
Journal of Biological Chemistry, 2000, 275, 6733-6740
2.3109Citations (PDF)
123Synthesis and Preclinical Evaluation of Glycoconjugate Vaccines against Group BStreptococcusTypes VI and VIII
Journal of Infectious Diseases, 1999, 180, 892-895
4.039Citations (PDF)
124Safety and Immunogenicity of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccines for Group B Streptococcal Types Ia and Ib
Journal of Infectious Diseases, 1999, 179, 142-150
4.0187Citations (PDF)
125Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium
Carbohydrate Research, 1999, 316, 155-160
2.334Citations (PDF)
126Ozonolytic depolymerization of polysaccharides in aqueous solution
Carbohydrate Research, 1999, 319, 141-147
2.369Citations (PDF)
127Cognate Stimulatory B-Cell–T-Cell Interactions Are Critical for T-Cell Help Recruited by Glycoconjugate Vaccines
Infection and Immunity, 1999, 67, 6375-6384
2.898Citations (PDF)
128Isolation and Chemical Characterization of a Capsular Polysaccharide Antigen Shared by Clinical Isolates of <i>Enterococcus faecalis</i> and Vancomycin-Resistant <i>Enterococcus faecium</i>
Infection and Immunity, 1999, 67, 1213-1219
2.8131Citations (PDF)
129Alpha C Protein as a Carrier for Type III Capsular Polysaccharide and as a Protective Protein in Group B Streptococcal Vaccines
Infection and Immunity, 1999, 67, 2491-2496
2.851Citations (PDF)
130Analysis of a Capsular Polysaccharide Biosynthesis Locus of<i>Bacteroides fragilis</i>
Infection and Immunity, 1999, 67, 3525-3532
2.853Citations (PDF)
131Measurement of Human Antibodies to Type III Group B <b> <i>Streptococcus</i> </b>
Infection and Immunity, 1999, 67, 4303-4305
2.814Citations (PDF)
132Interstrain Variation of the Polysaccharide B Biosynthesis Locus of Bacteroides fragilis : Characterization of the Region from Strain 638R
Journal of Bacteriology, 1999, 181, 6192-6196
3.016Citations (PDF)
133Immunologic Memory Induced by a Glycoconjugate Vaccine in a Murine Adoptive Lymphocyte Transfer Model
Infection and Immunity, 1998, 66, 2026-2032
2.861Citations (PDF)
134Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy
Infection and Immunity, 1998, 66, 2186-2192
2.867Citations (PDF)
135NMR and Molecular Dynamics Studies of the Conformational Epitope of the Type III Group BStreptococcusCapsular Polysaccharide and Derivatives†
Biochemistry, 1997, 36, 3278-3292
2.9110Citations (PDF)
136Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular Polysaccharide
Journal of Biological Chemistry, 1996, 271, 8786-8790
2.383Citations (PDF)
137Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1
Carbohydrate Research, 1995, 275, 333-341
2.37Citations (PDF)
138Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy
Carbohydrate Research, 1995, 277, 1-9
2.353Citations (PDF)
139Structure of the Type VI Group BStreptococcusCapsular Polysaccharide Determined by High Resolution NMR Spectroscopy1.026Citations (PDF)
140The Changing Spectrum of Group B Streptococcal Disease
New England Journal of Medicine, 1993, 328, 1843-1844
25.155Citations (PDF)
141Group B Streptococcus Type III Glycoconjugate Vaccines.0.05Citations (PDF)
142Response to Type III Polysaccharide in Women Whose Infants Have Had Invasive Group B Streptococcal Infection
New England Journal of Medicine, 1990, 322, 1857-1860
25.138Citations (PDF)
143Structure of the capsular polysaccharide antigen of type IV group B Streptococcus1.731Citations (PDF)
144Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus
New England Journal of Medicine, 1988, 319, 1180-1185
25.1320Citations (PDF)
145A Novel Approach to N-Acetyl-neuraminic Acid-Containing Oligosaccharides. Synthesis of a Glycosyl Donor Derivative of α-<u>N</u>-Acetyl-D-neuraminyl- (2-6) -D-galactose1.015Citations (PDF)
1464,8-Anhydro-N-acetylneuraminic acid. Isolation from edible bird's nest and structure determination
FEBS Journal, 1987, 162, 445-450
0.236Citations (PDF)
147Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody
Microbial Pathogenesis, 1986, 1, 191-204
3.224Citations (PDF)
148Immunity to group B Streptococcus0.11Citations (PDF)
149Effect of Subinhibitory Doses of Clindamycin on the Virulence of Bacteroides fragilis: Role of Lipopolysaccharide4.015Citations (PDF)
150Case 4-198625.16Citations (PDF)
151Characterization of Bacteroides fragilis Strains Based on Antigen-Specific Immunofluorescence
Journal of Infectious Diseases, 1983, 147, 780-780
4.020Citations (PDF)
152Antibody to type III group B Streptococcus in the rhesus monkey1.315Citations (PDF)
153Antibody-Independent Activation of C1 by Type Ia Group B Streptococci
Journal of Infectious Diseases, 1982, 146, 665-672
4.036Citations (PDF)
154Evidence for T Cell-dependent Immunity to Bacteroides fragilis in an Intraabdominal Abscess Model9.193Citations (PDF)
155Antibody-independent Classical Pathway-mediated Opsonophagocytosis of Type Ia, Group B Streptococcus9.166Citations (PDF)
156Characterization of Serum Resistance of Neisseria gonorrhoeae that Disseminate9.188Citations (PDF)
157Lack of stimulation of isohemagglutinin antibodies byimmunization with group B streptococcal (Type III) vaccine
Journal of Pediatrics, 1981, 99, 918-920
2.02Citations (PDF)
158Structure and Conformation of the Capsular Polysaccharides of Group B Streptococcus
ACS Symposium Series, 1981, , 161-172
1.00Citations (PDF)
159The natural history of group B streptococcal colonization in the pregnant woman and her offspring1.363Citations (PDF)
160Influence of Preimmunization Antibody Levels on the Specificity of the Immune Response to Related Polysaccharide Antigens25.159Citations (PDF)
161Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae
Journal of Pediatrics, 1980, 97, 364-369
2.0107Citations (PDF)
162Enzymic synthesis of 5-acetamido-9-azido-3,5,9-trideoxy--glycero--galacto-2-nonulosonic acid, a 9-azido-9-deoxy derivative of N-acetylneuraminic acid2.169Citations (PDF)
163Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus1.499Citations (PDF)
164Group B streptococcal colonization and antibody status in lower socioeconomic parturient women1.335Citations (PDF)
165Isolation and Identification of Encapsulated Strains of Bacteroides fragilis4.0111Citations (PDF)
166Purification and Immunochemical Characterization of the Outer Membrane Complex of Bacteroides melaninogenicus Subspecies asaccharolyticus
Journal of Infectious Diseases, 1977, 135, 787-799
4.094Citations (PDF)
167Characterization of Gonococcal Antigens Responsible for Induction of Bactericidal Antibody in Disseminated Infection9.1108Citations (PDF)
168Chemical and Biological Characterization of the Lipopolysaccharide of Bacteroides fragilis Subspecies fragilis4.0143Citations (PDF)
169Correlation of Maternal Antibody Deficiency with Susceptibility to Neonatal Group B Streptococcal Infection25.1699Citations (PDF)